Robert Berman, MD

Robert Berman is a biotech neuroscientist and entrepreneur who has worked in academia, at the Yale School of Medicine Department of Psychiatry, and led clinical development teams at Pfizer and BMS. He co-founded Biohaven Pharmaceuticals (NYSE:BHVN) in 2013 and served as CMO until 2019. He currently serves on boards and as an advisor to multiple start-ups.